ArticleKidney diseases (Basel, Switzerland)
Dynamic and Individualized Prediction of Acute Kidney Injury via Longitudinal Peripheral Blood Cell Trajectories among COVID-19 Inpatients: A Multicenter Prospective Cohort Study.
Article in Kidney diseases (Basel, Switzerland). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Acute kidney injury (AKI) is a serious complication of COVID-19 inpatients, requiring early identification of high-risk individuals by dynamic biomarkers. We evaluated the association between longitudinal peripheral blood count (PBC) trajectories and AKI in these patients by joint model analysis. Methods: In a prospective cohort of 3,691 hospitalized adults with COVID-19 from six tertiary hospitals in China, longitudinal lymphocyte, neutrophil, and platelet counts and four derived ratios (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], neutrophil-to-platelet ratio [NPR], and neutrophil-to-lymphocyte-platelet ratio [NLPR]) were analyzed. A joint model was performed to evaluate the associations between PBC trajectories and in-hospital AKI. PBC thresholds on admission were identified by restricted cubic splines for further stratified joint model analyses. Competing-risk joint models were then performed to evaluate the associations between PBC trajectories and renal recovery. Results: Among 3,691 COVID-19 inpatients, 768 (20.8%) developed AKI during hospitalization. Joint model analysis revealed that trajectories of all seven PBC parameters were significantly associated with AKI risk (all Conclusion: By joint model analyses, dynamic PBC trajectories enabled individualized, real-time AKI risk evaluation in COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.